Monensin, salinomycin and narasin were detectable in six, two and one,
respectively, out of 161 eggs surveyed in Northern Ireland in 1994. I
n all cases, the concentrations detected were less than 2.5ng/g. Lasal
ocid was detectable in 107 eggs at concentrations ranging from 0.3 to
129 ng/g. Cross-contamination of unmedicated feeds with monensin durin
g feed manufacture (up to eight batches of unmedicated feed contaminat
ed with monensin) was similar to that previously observed for lasaloci
d (up to nine batches contaminated). Therefore differences in the inci
dence in eggs could not be explained by differential carry-over during
feed manufacture e. In a feeding trial it was shown that the relative
ability of monensin, salinomycin and lasalocid to accumulate in eggs
was in the ratio 0.12.3.3:63 ng/g egg per mg/kg feed, respectively. Th
is indicated that the potential for monensin and salinomycin to cause
I residues in eggs was very low, by comparison with lasalocid In 1995,
a granular formulation of the lasalocid premix was introduced into th
e United Kingdom that dea eased the carry-over of this dr drug from me
dicated to unmedicated feed. Six months after the introduction of this
formulation, the incidence of lasalocid residues in eggs (21%) was lo
wer than that found (66.5%) in an earlier survey (1994) carried out, a
nd published, by this laboratory.